Document Report Card

Basic Information

ID: ALA1141596

Journal: Bioorg Med Chem Lett

Title: A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity.

Authors: Feng DM, DiPardo RM, Wai JM, Chang RK, Di Marco CN, Murphy KL, Ransom RW, Reiss DR, Tang C, Prueksaritanont T, Pettibone DJ, Bock MG, Kuduk SD.

Abstract: The design and synthesis of a novel class of human bradykinin B1 antagonists featuring difluoroethyl ether and isoxazole carboxamide moieties are disclosed. Compound 7g displayed excellent pharmacokinetic properties, efficient ex vivo receptor occupancy, and low potential for P450 induction via PXR activation.

CiteXplore: 18240388

DOI: 10.1016/j.bmcl.2007.11.057